All patients with either bipolar I or II disorders were included. No exclusion criteria existed. All diagnoses were confirmed in a weekly consensus meeting where at least two senior psychiatrists with expertise in SCID, at least one of whom knew the patient, participated. The patients were interviewed with a Norwegian adaptation of the Network Entry Questionnaire used by the Bipolar Collaboration Network (BCN) 10, 11 where age at onset is defined as 'their first depressive symptoms associated with dysfunction (a definition that would be likely to meet DSM-IV criteria), as well as their first hypomanic or manic symptoms similar to those experienced in adulthood'. 1, 3 Information was also collected from the patients' families and records. First pharmacological treatment for depression or hypomania/mania and age at first admission to a psychiatric department for an affective episode were recorded. Psychosis was defined as lifetime admission to hospital with a psychotic illness. The patients were divided into four groups according to age at onset, defined much as in the BCN Categorical variables were analysed with chi-squared tests. Continuous measures were examined using one-way analyses of variance (ANOVA) with the four age groups. The Tamhanes test for equal variances not assumed was used post hoc for comparisons between groups. The results were confirmed with the KruskalWallis test for the four age groups. Correlations were done using Spearman's rho correlation test.
Results
Demographic and clinical characteristics for the four age groups are presented in Table 1 and online Table DS1 .
The duration from onset to first pharmacological treatment (r = 70.695, P50.01) and the duration from onset to first admission to hospital (r = 70.677, P50.01) were inversely correlated with age at onset.
Patients with lifetime psychosis were younger at first treatment (mean 27.6 v. 31.2 years, P = 0.050) and first admission to hospital (29.2 v. 35.8 years, P50.001) and had shorter time to first treatment (7.2 v. 10.9 years, P = 0.038) and to first admission to hospital (8.9 v. 15.7 years, P = 0.001). Patients with rapid cycling were younger at first episode (15.4 v. 21.7 years, P = 0.005) and at first treatment (25.2 years v. 30.5 years, P = 0.016) and had shorter time to first admission (8.9 v. 15.7 years, P = 0.001). Patients with bipolar I disorder were younger at first admission (30.5 v. 36.3 years, P = 0.024) and had a shorter time from first episode to first admission (10.7 v. 16 years, P = 0.015) than patients with bipolar II disorder.
Discussion
The proportion of patients with childhood onset was similar (23%) to that in the STEP-BD study from the USA (27.7%) 5 and from US centres of the BCN study (22%), 1 but differed from European centres (The Netherlands and Germany) of the same BCN study (2%). 1 The mean age at first treatment was 26 years among patients with onset before 30 years of age. This finding is similar to that
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of the BCN study (estimated 27 years) 3 and indicates a long period with inadequate treatment for patients with early-onset bipolar disorder, or that patients with a young age at onset have a slower symptom development or fewer characteristic symptoms.
The distribution of time to first treatment between age groups was much the same as in USA and European out-patients, 3 illustrating that there is a problem treating patients early enough even in countries such as Norway, where everyone has access to health services.
A limitation of the study was that data were based on retrospective information from patients.
Age at onset of the first affective episode is much the same in Norwegian in-patients as in out-patients in the USA. Time from the first affective episode to the first pharmacological treatment and to the first hospital admission was inversely correlated with the age at first affective episode. This indicates a need for more focus on the early phases of bipolar disorder in psychiatric services. .001 between all groups; **P<0.001 between adults and every other group; ***P = 0.011 between childhood and adolescents, P<0.001 between childhood and young adults and adults, and adolescents and adults, P = 0.001 between adolescents and young adults; ****P=0.001 between childhood and adolescents, between childhood and young adult and adult, and between adolescent and adult, P = 0.002 between adolescent and young adult.
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